Key Points
-
Interested in Relx Plc? Here are five stocks we like better.
-
Elsevier’s STM revenue growth has accelerated to 6%, up from 2%–4% at its prior investor seminar. The division represented 28% of RELX revenue and 30% of adjusted operating profit in the first half of 2026, with about 80% of revenue subscription-based.
-
RELX is expanding AI-enabled research and healthcare tools: nearly 1,000 institutional customers have subscribed to LeapSpace, and Sherpath AI reached 100,000 students in 2026. The company says these products aim to improve research and nursing workflows while supporting further growth.
-
Elsevier is scaling publishing while emphasizing quality controls: it received 4.2 million article submissions annually and published more than 800,000 articles in 2025, accepting fewer than 20% of submissions. Its screening processes…
